RxDoctor Payments Data

Lexandria Pascarella, PA

Physician Assistant · Olean, NYNPI 1528541869

Payments from drug & device makers

$829in general payments, 2019–2025

Across 37 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$170
  • Sumitomo Pharma America, Inc.$137
  • Lilly USA, LLC$95
  • Johnson & Johnson$92
  • AbbVie$78
  • GSK$70
  • plus $187 from 7 others

What the payments were for

  • Food & beverage$829100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$829 in reported general payments places this provider in the 70th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$6,137
Medicare patients
55
Services billed
85

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban22$24,399
OzempicSemaglutide14$22,976
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$20,282
MounjaroTirzepatide17$19,888
JanuviaSitagliptin Phosphate13$11,696
MyrbetriqMirabegron11$10,560
GemtesaVibegron13$6,420
Metoprolol Succinate71$1,151
Levothyroxine Sodium92$1,112
Rosuvastatin Calcium61$1,000
Lisinopril111$823
Albuterol Sulfate HfaAlbuterol Sulfate18$812
Omeprazole68$784
Kapspargo SprinkleMetoprolol Succinate12$714
Simvastatin53$679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$92$24,39922 claims
Novo NordiskOzempic$170$22,97614 claims
GSKTrelegy Ellipta$70$20,28222 claims
Lilly USA, LLCMounjaro$95$19,88817 claims
Sumitomo Pharma America, Inc.Gemtesa$137$6,42013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Olean

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →